{"id":13460,"date":"2025-10-29T09:53:10","date_gmt":"2025-10-29T13:53:10","guid":{"rendered":"https:\/\/clario.com\/?post_type=newsroom&#038;p=13460"},"modified":"2025-10-29T09:53:14","modified_gmt":"2025-10-29T13:53:14","slug":"thermo-fisher-scientific-to-acquire-clario-enabling-pharma-and-biotech-customers-to-accelerate-innovation-with-deeper-clinical-insights","status":"publish","type":"newsroom","link":"https:\/\/clario.com\/about\/newsroom\/thermo-fisher-scientific-to-acquire-clario-enabling-pharma-and-biotech-customers-to-accelerate-innovation-with-deeper-clinical-insights\/","title":{"rendered":"Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights"},"content":{"rendered":"\n<p>Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.<\/p>\n\n\n\n<p><a href=\"https:\/\/newsroom.thermofisher.com\/newsroom\/press-releases\/press-release-details\/2025\/Thermo-Fisher-Scientific-to-Acquire-Clario-Holdings-Inc--Enabling-Pharma-and-Biotech-Customers-to-Accelerate-Innovation-with-Deeper-Clinical-Insights\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">Read the full press release on the Thermo Fisher Scientific website<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","tags":[102],"solution_areas":[],"therapeutic_area":[],"class_list":["post-13460","newsroom","type-newsroom","status-publish","hentry","tag-press-release"],"acf":[],"cp_meta_data":{"_edit_lock":["1761746716:7"],"_edit_last":["7"],"media_coverage_logo":[""],"_media_coverage_logo":["field_62c529f1ff80c"],"media_coverage_color_logo":[""],"_media_coverage_color_logo":["field_630f051a114db"],"page_title":[""],"_page_title":["field_615dbd9cfca50"],"display_prefooter":["hide"],"_display_prefooter":["field_61641783f0f7c"],"persistent_cta":["hide"],"_persistent_cta":["field_6375dc7c0b25c"],"show_popup":["0"],"_show_popup":["field_62b1aec56dcb5"],"_ame_cpe_post_policy":["{\"accessProtection\":{\"active\":\"replace\"}}"],"_yoast_wpseo_content_score":["90"],"_yoast_wpseo_focuskeywords":[""],"_yoast_wpseo_keywordsynonyms":[""],"_yoast_wpseo_estimated-reading-time-minutes":["1"],"_yoast_indexnow_last_ping":["1761745995"]},"_links":{"self":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/newsroom\/13460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/newsroom"}],"about":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/types\/newsroom"}],"version-history":[{"count":0,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/newsroom\/13460\/revisions"}],"wp:attachment":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/media?parent=13460"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/tags?post=13460"},{"taxonomy":"solution_areas","embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/solution_areas?post=13460"},{"taxonomy":"therapeutic_area","embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/therapeutic_area?post=13460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}